CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress
RATIONALE: Cardiac CITED4 (CBP/p300-interacting transactivators with E [glutamic acid]/D [aspartic acid]-rich-carboxylterminal domain4) is induced by exercise and is sufficient to cause physiological hypertrophy and mitigate adverse ventricular remodeling after ischemic injury. However, the role of endogenous CITED4 in response to physiological or pathological stress is unknown.
OBJECTIVE: To investigate the role of CITED4 in murine models of exercise and pressure overload.
METHODS AND RESULTS: We generated cardiomyocyte-specific CITED4 knockout mice (C4KO) and subjected them to an intensive swim exercise protocol as well as transverse aortic constriction (TAC). Echocardiography, Western blotting, qPCR, immunohistochemistry, immunofluorescence, and transcriptional profiling for mRNA and miRNA (microRNA) expression were performed. Cellular crosstalk was investigated in vitro. CITED4 deletion in cardiomyocytes did not affect baseline cardiac size or function in young adult mice. C4KO mice developed modest cardiac dysfunction and dilation in response to exercise. After TAC, C4KOs developed severe heart failure with left ventricular dilation, impaired cardiomyocyte growth accompanied by reduced mTOR (mammalian target of rapamycin) activity and maladaptive cardiac remodeling with increased apoptosis, autophagy, and impaired mitochondrial signaling. Interstitial fibrosis was markedly increased in C4KO hearts after TAC. RNAseq revealed induction of a profibrotic miRNA network. miR30d was decreased in C4KO hearts after TAC and mediated crosstalk between cardiomyocytes and fibroblasts to modulate fibrosis. miR30d inhibition was sufficient to increase cardiac dysfunction and fibrosis after TAC.
CONCLUSIONS: CITED4 protects against pathological cardiac remodeling by regulating mTOR activity and a network of miRNAs mediating cardiomyocyte to fibroblast crosstalk. Our findings highlight the importance of CITED4 in response to both physiological and pathological stimuli.
| Errataetall: |
CommentIn: Circ Res. 2020 Aug 14;127(5):647-650. - PMID 32790523 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:127 |
|---|---|
| Enthalten in: |
Circulation research - 127(2020), 5 vom: 14. Aug., Seite 631-646 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lerchenmüller, Carolin [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.05.2021 Date Revised 12.02.2022 published: Print-Electronic CommentIn: Circ Res. 2020 Aug 14;127(5):647-650. - PMID 32790523 Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIRCRESAHA.119.315881 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310011450 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310011450 | ||
| 003 | DE-627 | ||
| 005 | 20231225135152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCRESAHA.119.315881 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM310011450 | ||
| 035 | |a (NLM)32418505 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lerchenmüller, Carolin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.05.2021 | ||
| 500 | |a Date Revised 12.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Circ Res. 2020 Aug 14;127(5):647-650. - PMID 32790523 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a RATIONALE: Cardiac CITED4 (CBP/p300-interacting transactivators with E [glutamic acid]/D [aspartic acid]-rich-carboxylterminal domain4) is induced by exercise and is sufficient to cause physiological hypertrophy and mitigate adverse ventricular remodeling after ischemic injury. However, the role of endogenous CITED4 in response to physiological or pathological stress is unknown | ||
| 520 | |a OBJECTIVE: To investigate the role of CITED4 in murine models of exercise and pressure overload | ||
| 520 | |a METHODS AND RESULTS: We generated cardiomyocyte-specific CITED4 knockout mice (C4KO) and subjected them to an intensive swim exercise protocol as well as transverse aortic constriction (TAC). Echocardiography, Western blotting, qPCR, immunohistochemistry, immunofluorescence, and transcriptional profiling for mRNA and miRNA (microRNA) expression were performed. Cellular crosstalk was investigated in vitro. CITED4 deletion in cardiomyocytes did not affect baseline cardiac size or function in young adult mice. C4KO mice developed modest cardiac dysfunction and dilation in response to exercise. After TAC, C4KOs developed severe heart failure with left ventricular dilation, impaired cardiomyocyte growth accompanied by reduced mTOR (mammalian target of rapamycin) activity and maladaptive cardiac remodeling with increased apoptosis, autophagy, and impaired mitochondrial signaling. Interstitial fibrosis was markedly increased in C4KO hearts after TAC. RNAseq revealed induction of a profibrotic miRNA network. miR30d was decreased in C4KO hearts after TAC and mediated crosstalk between cardiomyocytes and fibroblasts to modulate fibrosis. miR30d inhibition was sufficient to increase cardiac dysfunction and fibrosis after TAC | ||
| 520 | |a CONCLUSIONS: CITED4 protects against pathological cardiac remodeling by regulating mTOR activity and a network of miRNAs mediating cardiomyocyte to fibroblast crosstalk. Our findings highlight the importance of CITED4 in response to both physiological and pathological stimuli | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a exercise | |
| 650 | 4 | |a extracellular matrix | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a signal transduction | |
| 650 | 7 | |a Cited4 protein, mouse |2 NLM | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a Mirn30d microRNA, mouse |2 NLM | |
| 650 | 7 | |a Transcription Factors |2 NLM | |
| 650 | 7 | |a mTOR protein, mouse |2 NLM | |
| 650 | 7 | |a EC 2.7.1.1 |2 NLM | |
| 650 | 7 | |a TOR Serine-Threonine Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 700 | 1 | |a Rabolli, Charles P |e verfasserin |4 aut | |
| 700 | 1 | |a Yeri, Ashish |e verfasserin |4 aut | |
| 700 | 1 | |a Kitchen, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Salvador, Ane M |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Laura X |e verfasserin |4 aut | |
| 700 | 1 | |a Ziegler, Olivia |e verfasserin |4 aut | |
| 700 | 1 | |a Danielson, Kirsty |e verfasserin |4 aut | |
| 700 | 1 | |a Platt, Colin |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Ravi |e verfasserin |4 aut | |
| 700 | 1 | |a Damilano, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Kundu, Piyusha |e verfasserin |4 aut | |
| 700 | 1 | |a Riechert, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Katus, Hugo A |e verfasserin |4 aut | |
| 700 | 1 | |a Saffitz, Jeffrey E |e verfasserin |4 aut | |
| 700 | 1 | |a Keshishian, Hasmik |e verfasserin |4 aut | |
| 700 | 1 | |a Carr, Steven A |e verfasserin |4 aut | |
| 700 | 1 | |a Bezzerides, Vassilios J |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Saumya |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenzweig, Anthony |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation research |d 1953 |g 127(2020), 5 vom: 14. Aug., Seite 631-646 |w (DE-627)NLM000001910 |x 1524-4571 |7 nnns |
| 773 | 1 | 8 | |g volume:127 |g year:2020 |g number:5 |g day:14 |g month:08 |g pages:631-646 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCRESAHA.119.315881 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 127 |j 2020 |e 5 |b 14 |c 08 |h 631-646 | ||